Methylnaltrexone Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Relistor™

Filter by location:

Houston, Texas1 trial

Methylnatrexone In Resectable Head and Neck Squamous Cell Carcinoma (MINK). A "Window of Opportunity" Pilot Study.

MD Anderson Cancer Center

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.